Literature DB >> 7049625

Adrenergic modulation of gastric inhibitory polypeptide secretion in man.

M Salera, R Ebert, P Giacomoni, L Pironi, S Venturi, R Corinaldesi, M Miglioli, L Barbara.   

Abstract

In order to examine the effect of adrenergic influences on gastric inhibitory polypeptide (GIP) secretion, a series of glucose tolerance tests was carried out in seven healthy volunteers during intravenous infusion of epinephrine (6 microgram/min), epinephrine plus phentolamine (5 mg stat + 0.5 mg/min), epinephrine plus propranolol (5 mg stat + 0.08 mg/min), and saline. No drug infusion modified fasting GIP levels. Alpha-adrenergic stimulation (epinephrine + propranolol) significantly reduced the GIP response (P less than 0.02) and completely inhibited the insulin response (P less than 0.005) to oral glucose, compared with control experiments. Epinephrine alone and epinephrine + phentolamine did not influence glucose-stimulated GIP. These results suggest the possibility that the adrenergic nervous system may have a role in the regulation of GIP secretion in man.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7049625     DOI: 10.1007/bf01391372

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  23 in total

1.  Release of immunoreactive gastric inhibitory polypeptide (IR-GIP) by oral ingestion of food substances.

Authors:  I G Cleator; R H Gourlay
Journal:  Am J Surg       Date:  1975-08       Impact factor: 2.565

Review 2.  Identification and actions of gastric inhibitory polypeptide.

Authors:  J C Brown; J R Dryburgh; S A Ross; J Dupré
Journal:  Recent Prog Horm Res       Date:  1975

3.  The insulinotropic effect of endogenous gastric inhibitory polypeptide in normal subjects.

Authors:  S E Crockett; S Cataland; J M Falko; E L Mazzaferri
Journal:  J Clin Endocrinol Metab       Date:  1976-06       Impact factor: 5.958

Review 4.  The incretin concept today.

Authors:  W Creutzfeldt
Journal:  Diabetologia       Date:  1979-02       Impact factor: 10.122

5.  Stimulation of insulin secretion by gastric inhibitory polypeptide in man.

Authors:  J Dupre; S A Ross; D Watson; J C Brown
Journal:  J Clin Endocrinol Metab       Date:  1973-11       Impact factor: 5.958

6.  Gastric inhibitory polypeptide and insulin secretion after infusion of acetylcholine, catecholamines, and gut hormones.

Authors:  R H Williams; J Biesbroeck
Journal:  Proc Soc Exp Biol Med       Date:  1980-01

7.  Release of gastric inhibitory polypeptide (GIP) by intraduodenal acidification in rats and humans and abolishment of the incretin effect of acid by GIP-antiserum in rats.

Authors:  R Ebert; K Illmer; W Creutzfeldt
Journal:  Gastroenterology       Date:  1979-03       Impact factor: 22.682

8.  Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.

Authors:  D K Andersen; D Elahi; J C Brown; J D Tobin; R Andres
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

9.  Gastric inhibitory polypeptide (GIP) stimulation by oral glucose in man.

Authors:  S Cataland; S E Crockett; J C Brown; E L Mazzaferri
Journal:  J Clin Endocrinol Metab       Date:  1974-08       Impact factor: 5.958

10.  Lowering of fasting and food stimulated serum immunoreactive gastric inhibitory polypeptide (GIP) by glucagon.

Authors:  R Ebert; R Arnold; W Creutzfeldt
Journal:  Gut       Date:  1977-02       Impact factor: 23.059

View more
  2 in total

1.  Terbutaline, a beta 2-adrenoreceptor agonist, inhibits gastric acid secretion and stimulates release of peptide YY and gastric inhibitory polypeptide in dogs.

Authors:  M Kogire; M Izukura; G Gomez; T Uchida; G H Greeley; J C Thompson
Journal:  Dig Dis Sci       Date:  1990-04       Impact factor: 3.199

2.  Effects of physiological increases of plasma noradrenaline on gastric acid secretion and gastrointestinal hormones.

Authors:  H Graffner; S R Bloom; L O Farnebo; J Järhult
Journal:  Dig Dis Sci       Date:  1987-07       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.